Third dose of COVID-19 vaccine recommended for immunocompromised people
Immunocompromised people who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose to improve their chances of developing an adequate antibody response, the US Centers for Disease Control recommended earlier this month.
The recommendation applies to people who are receiving immunosuppressive treatment for cancer and to people with HIV with low CD4 counts or detectable HIV viral load (although US CDC doesn’t specify what CD4 threshold should trigger eligibility for a third dose).
Immunocompromised people are those who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
You can read the full article here.